Deals In Depth: February 2018
Executive Summary
Bristol-Myers Squibb and Nektar cemented a $3.6 billion immuno-oncology combination deal centered on an earlier trial collaboration. Roche acquired Flatiron Health and its software capabilities in mining electronic medical records for $1.9 billion. Moderna, Procept BioRobotics, and HeartFlow each raised big late-stage rounds.